Gastrointestinal mixed adenoneuroendocrine carcinoma (MANEC): An immunohistochemistry study of 13 microsatellite stable cases

Pathol Res Pract. 2019 Dec;215(12):152697. doi: 10.1016/j.prp.2019.152697. Epub 2019 Oct 23.

Abstract

Background: Mixed adenoneuroendocrine carcinoma (MANEC) is currently included in the category of neuroendocrine carcinomas but the therapeutically management is not yet defined.

Aims: To present the immunohistochemical (IHC) features of the epithelial mesenchymal transition (EMT) of MANEC.

Materials and methods: The clinicopathological features of 13 consecutive cases of MANEC (6 gastric and 7 colorectal) were correlated with the IHC expression of the biomarkers E-cadherin, β-catenin, N-cadherin, vimentin, maspin, CD44 and S100. In all of the cases open surgery was performed.

Results: All of the cases showed microsatellite stable status, expressed E-cadherin and membrane β-catenin in both components (neuroendocrine and adenocarcinoma) and were negative for N-cadherin, vimentin and S-100. The colorectal MANECs were negative for maspin. In gastric MANECs, maspin showed cytoplasm positivity in the neuroendocrine component and nuclear translocation in the adenocarcinoma cells. CD44 was positive in all of the cases, in both components. No tumor buddings were identified. Three of the 13 patients survived for at least 32 months, all of them showing lymphatic emboli but not lymph node metastases. Pure neuroendocrine lymph node metastases were seen in only four of the cases: one from stomach, two of the ascending colon and two cases of the upper rectum.

Conclusions: Gastrointestinal MANEC is a microsatellite stable tumor with nodular growth, which components might originate from a CD44-positive stem-like precursor cell. Lymph node status remains the most reliable prognostic parameter and agressivity seems to not be influenced by tumor budding degree or EMT-related features. The histologic aspect of metastatic component (neuroendocrine versus adenocarcinoma) should be included in the histopathological reports and might be used for establishing the proper-targeted therapy of MANEC.

Keywords: Beta-catenin; CD44; Epithelial mesenchymal transition; Lymph node architecture; MANEC; Maspin.

MeSH terms

  • Adenocarcinoma / chemistry*
  • Adenocarcinoma / genetics
  • Adenocarcinoma / mortality
  • Adenocarcinoma / secondary
  • Aged
  • Biomarkers, Tumor / analysis*
  • Carcinoma, Neuroendocrine / chemistry*
  • Carcinoma, Neuroendocrine / genetics
  • Carcinoma, Neuroendocrine / mortality
  • Carcinoma, Neuroendocrine / secondary
  • Epithelial-Mesenchymal Transition
  • Female
  • Gastrointestinal Neoplasms / chemistry*
  • Gastrointestinal Neoplasms / genetics
  • Gastrointestinal Neoplasms / mortality
  • Gastrointestinal Neoplasms / pathology
  • Humans
  • Immunohistochemistry*
  • Lymphatic Metastasis
  • Male
  • Microsatellite Repeats*
  • Middle Aged
  • Neoplasms, Complex and Mixed / chemistry*
  • Neoplasms, Complex and Mixed / genetics
  • Neoplasms, Complex and Mixed / mortality
  • Neoplasms, Complex and Mixed / secondary
  • Predictive Value of Tests
  • Prognosis
  • Retrospective Studies

Substances

  • Biomarkers, Tumor